Greg Yap invests in life sciences, healthcare and therapeutic platforms at Menlo Ventures. Before joining the firm, he was an entrepreneur in residence at Illumina Ventures and co-founded and led BlueLight Therapeutics and PyrAmes. His earlier roles included leading a cancer diagnostics business at Roche Diagnostics/Ventana, healthcare entrepreneurship at GE, COO of Cellpoint Diagnostics, vice president and general manager at Affymetrix, and consulting at McKinsey. He serves on the board of Outward Bound California.
Greg Yap invests in life sciences, healthcare and therapeutic platforms at Menlo Ventures. Before joining the firm, he was an entrepreneur in residence at Illumina Ventures and co-founded and led BlueLight Therapeutics and PyrAmes. His earlier roles included leading a cancer diagnostics business at Roche Diagnostics/Ventana, healthcare entrepreneurship at GE, COO of Cellpoint Diagnostics, vice president and general manager at Affymetrix, and consulting at McKinsey. He serves on the board of Outward Bound California.
Career
Greg Yap holds an MBA from Stanford University.
Partner at Menlo Ventures from 2017 to PresentOBBoard Member at Outward Bound California until Present
